Statement Of Cash Flows [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
2020-01-01 to 2020-12-31 |
As at 2019-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Statement of cash flows [abstract] | |||||||||
| Cash flows from (used in) operating activities [abstract] | |||||||||
| Profit (loss) | — |
31,490,000
EUR
|
12,953,000
EUR
|
44,443,000
EUR
|
— |
35,389,000
EUR
|
23,550,000
EUR
|
11,839,000
EUR
|
— |
| Adjustments to reconcile profit (loss) [abstract] | |||||||||
| Adjustments for income tax expense | — | — | — |
473,000
EUR
|
— |
106,000
EUR
|
— | — | — |
| Cash flows from (used in) operations | — | — | — |
11,449,000
EUR
|
— |
15,009,000
EUR
|
— | — | — |
| Cash flows from (used in) operating activities | — | — | — |
11,449,000
EUR
|
— |
15,009,000
EUR
|
— | — | — |
| Cash flows from (used in) investing activities [abstract] | |||||||||
| Cash flows from (used in) investing activities | — | — | — |
193,558,000
EUR
|
— |
46,257,000
EUR
|
— | — | — |
| Cash flows from (used in) financing activities [abstract] | |||||||||
| Proceeds from issuing shares | — | — | — |
168,477,000
EUR
|
— |
11,553,000
EUR
|
— | — | — |
| Proceeds from borrowings, classified as financing activities | — | — | — |
68,860,000
EUR
|
— |
35,201,000
EUR
|
— | — | — |
| Repayments of borrowings, classified as financing activities | — | — | — |
36,500,000
EUR
|
— |
-
EUR
|
— | — | — |
| Dividends paid, classified as financing activities | — | — | — |
16,188,000
EUR
|
— |
13,508,000
EUR
|
— | — | — |
| Interest paid, classified as financing activities | — | — | — |
1,311,000
EUR
|
— |
1,588,000
EUR
|
— | — | — |
| Cash flows from (used in) financing activities | — | — | — |
180,515,000
EUR
|
— |
31,543,000
EUR
|
— | — | — |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | — | — | — |
1,594,000
EUR
|
— |
295,000
EUR
|
— | — | — |
| Cash and cash equivalents |
23,280,000
EUR
|
— | — | — |
24,874,000
EUR
|
— | — | — |
24,579,000
EUR
|